Diligence memo · auto-generated · as of July 2, 2026
Tissue Differentiation Intelligence, LLC
Tissue Differentiation Intelligence, LLC looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Tissue Differentiation Intelligence, LLC operates in AI / ML, based in DELRAY BEACH.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Tissue Differentiation Intelligence, LLC has raised $6.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $6.0M on 2017-12-20.
Most recent recorded round closed around 2017-12-20.
Valuation (modeled)modeled
Provath models Tissue Differentiation Intelligence, LLC at approximately $217M (range $8.0M–$1.2B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.20× the median modeled value of Series A AI / ML companies in 2016–2018 (13 peers) — value vs value, same stage and era. Within the normal band (120% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 8.5 yr ago; this sector typically re-raises about every 11 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 84% of AI / ML peers (2067 compared).
Modeled value ranks above 93% of those peers.
Closest niche peers: Sano Intelligence, Inc., Xnor.Ai, Inc., Unicorn ML, Inc., K2 Intelligence Holdings, Inc., Mapper.ai, Inc..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.